Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a <scp>S</scp> wiss cohort with obesity-Reference-Cited by-同舟云学术

Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a S wiss cohort with obesity

Published:2022-12-07 Issue:1 Volume:31 Page:74-82
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Santini Sara¹^ORCID,Vionnet Nathalie¹^ORCID,Pasquier Jérôme²^ORCID,Gonzalez‐Rodriguez Elena³⁴^ORCID,Fraga Montserrat⁵,Pitteloud Nelly¹⁴^ORCID,Favre Lucie¹⁴^ORCID

Affiliation:

1. Division of Endocrinology, Diabetology, and Metabolism Lausanne University Hospital Lausanne Switzerland

2. Center for Primary Care and Public Health (Unisanté) University of Lausanne Lausanne Switzerland

3. Interdisciplinary Center for Bone Diseases Lausanne University Hospital Lausanne Switzerland

4. Faculty of Biology and Medicine University of Lausanne Lausanne Switzerland

5. Division of Gastroenterology and Hepatology Centre Hospitalier Universitaire Vaudois Lausanne Switzerland

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.23596

Reference46 articles.

1. Mechanisms, Pathophysiology, and Management of Obesity

2. How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy Intake

3. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

4. Once-Weekly Semaglutide in Adults with Overweight or Obesity

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world study;eClinicalMedicine;2024-08

2. Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events;Frontiers in Pharmacology;2024-07-08

3. Liraglutide in the management of obesity: real world data (Portugal);Minerva Endocrinology;2024-07

4. Phenotyping of Obesity Treatment Candidates: A Narrative Review;Current Obesity Reports;2024-06-14

5. Sex-Differences in Response to Treatment with Liraglutide 3.0 mg;Journal of Clinical Medicine;2024-06-07